American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
68 hedge funds and large institutions have $763M invested in American Renal Associates Holdings, Inc in 2016 Q2 according to their latest regulatory filings, with 68 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Centerbridge Partners
New York
|
+$490M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$51.2M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$29.5M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$23.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.6M |
Top Sellers
ARA Hedge Fund Activity: Q2 2016 in Review
68 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q2 2016, worth a combined $763M.
Buyers outnumbered sellers: 68 funds opened new ARA positions and 0 closed out — a net gain of 68 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Centerbridge Partners, opening a new position worth an estimated $490M.
- 68 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $763M of American Renal Associates Holdings, Inc stock for Q2 2016.
- 68 funds opened new American Renal Associates Holdings, Inc positions in Q2 2016 and 0 closed out, a net change of +68 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q2 2016 was Centerbridge Partners, an estimated $490M added.
Based on aggregated 13F filings for Q2 2016.